Kestra Medical Technologies, Ltd. Common Stock (KMTS)vsNovartis AG ADR (NVS)
KMTS
Kestra Medical Technologies, Ltd. Common Stock
$27.24
-5.02%
HEALTHCARE · Cap: $1.63B
NVS
Novartis AG ADR
$150.62
+0.16%
HEALTHCARE · Cap: $267.60B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 53020% more annual revenue ($56.69B vs $106.73M). NVS leads profitability with a 22.5% profit margin vs -140.4%. NVS earns a higher WallStSmart Score of 51/100 (C-).
KMTS
Avoid28
out of 100
Grade: F
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for KMTS.
Margin of Safety
-56.8%
Fair Value
$93.67
Current Price
$150.62
$56.95 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 59.9% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 31 in profit
Strong operational efficiency at 34.6%
Keeps 23 of every $100 in revenue as profit
Generating 5.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -50.3% — below average capital efficiency
Negative free cash flow — burning cash
0.8% revenue growth
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : KMTS
The strongest argument for KMTS centers on Revenue Growth. Revenue growth of 59.9% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 22.5% and operating margin at 34.6%.
Bear Case : KMTS
The primary concerns for KMTS are EPS Growth, Market Cap, Return on Equity.
Bear Case : NVS
The primary concerns for NVS are Revenue Growth, Altman Z-Score, Debt/Equity.
Key Dynamics to Monitor
KMTS profiles as a hypergrowth stock while NVS is a value play — different risk/reward profiles.
KMTS is growing revenue faster at 59.9% — sustainability is the question.
NVS generates stronger free cash flow (5.6B), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NVS scores higher overall (51/100 vs 28/100), backed by strong 22.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Kestra Medical Technologies, Ltd. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?